Application of horse angelica liquid and gemcitabine in preparation of medicine for treating cancer
A gemcitabine, cancer technology, applied in drug combinations, pharmaceutical formulations, anti-tumor drugs, etc., can solve problems such as difficulty in administration routes, and achieve the effects of alleviating pain, reducing bladder irritation, and reducing serum VEGF levels
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0045] like figure 1 As shown, the preparation method of Maguili liquid provided by the embodiments of the present invention comprises:
[0046] S101, cold immersing Angelica sinensis for 0.5h to extract volatile oil by steam distillation to obtain Angelica sinensis volatile oil, distilled aqueous solution and medicinal residues;
[0047] S102, decocting the obtained medicinal dregs with verbena, red peony root, and astragalus membranaceus for 3 times, combining the decoction, filtering, merging the filtrate and the aqueous solution, and standing for 24 hours;
[0048] S103, filter, concentrate to nearly 50mL, add an appropriate amount of preservative and angelica volatile oil, adjust the total amount to 50mL, stir well, potting, and sterilize.
[0049] The embodiment of the present invention provides decocting the obtained dregs with verbena, red peony root, and astragalus for 3 times, including:
[0050] The amount of water added for the three decoctions was 10 times, 8 ti...
Embodiment 1
[0053] 1 Materials and methods
[0054] 1.1 Inclusion and exclusion criteria
[0055] Inclusion criteria: (1) Urology color Doppler ultrasound and cystoscopy showed bladder tumor on admission, and postoperative pathological diagnosis confirmed non-muscle-invasive bladder cancer; (2) Age 18-85 years old, patients with initial bladder cancer; ( 3) No lymph node and distant metastasis; (4) Patients who have signed informed consent, voluntarily choose and cooperate with treatment.
[0056] Exclusion criteria: (1) with a history of chemotherapy drug allergy; (2) with other organic and serious diseases; (3) with unsustainable bladder perfusion; (4) with abnormal liver and kidney function; (5) with other reasons Patients who cannot complete the treatment plan.
[0057] 1.2 General Information
[0058] A total of 66 patients with non-muscle invasive bladder cancer who were hospitalized in our department from October 2018 to June 2020 and met the inclusion criteria were selected, in...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com